• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Novartis AG (NVS)

Equity
Sell: $111.00|Buy: $114.29|Change: 0.82 (0.73%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Novartis develops and manufactures innovative drugs. Key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.

Address

Lichtstrasse 35
Basel
CHE
4056

Telephone

+41 613247944

Website

https://www.novartis.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Novartis AG First Quarter Earnings Conference Call for 20262026-04-29T14:00:00
Novartis AG First Quarter Earnings Results for 20262026-04-29T00:00:00
Novartis AG Annual General Meeting for 20262026-03-06T10:00:00
Novartis AG Fourth Quarter Earnings Conference Call for 20252026-01-30T14:00:00
Novartis AG Fourth Quarter Earnings Results for 20252026-01-30T00:00:00
Novartis AG Annual Report for 20252026-01-30T00:00:00
Novartis AG Third Quarter Earnings Result for 20252025-10-28T00:00:00
Novartis AG Third Quarter Earnings Conference Call for 20252025-10-28T00:00:00
Novartis AG Second Quarter Earnings Result for 20252025-07-17T00:00:00
Novartis AG Second Quarter Earnings Conference Call for 20252025-07-17T00:00:00
Novartis AG First Quarter Earnings Conference Call for 20252025-04-29T14:00:00
Novartis AG First Quarter Earnings Result for 20252025-04-29T00:00:00

Previous key dates

NameKey Date
Novartis AG First Quarter Earnings Conference Call for 20252025-04-29T14:00:00
Novartis AG First Quarter Earnings Result for 20252025-04-29T00:00:00
Novartis AG Annual General Meeting for 20252025-03-07T10:00:00
Novartis AG Fourth Quarter Earnings Conference Call for 20242025-01-31T14:00:00
Novartis AG Fourth Quarter Earnings Result for 20242025-01-31T00:00:00
Novartis AG Annual Report for 20242025-01-31T00:00:00
Novartis AG Third Quarter Earnings Conference Call for 20242024-10-29T14:00:00
Novartis AG Third Quarter Earnings Result for 20242024-10-29T00:00:00
Novartis AG Second Quarter Earnings Conference Call for 20242024-07-18T14:00:00
Novartis AG Second Quarter Earnings Result for 20242024-07-18T00:00:00
Novartis AG First Quarter Earnings Result for 20242024-04-23T00:00:00
Novartis AG First Quarter Earnings Conference Call for 20242024-04-23T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.